Which adverse effect is NOT associated with Calcium Gluconate?

Calcium gluconate is primarily used in conditions such as hypocalcemia, hyperkalemia, and magnesium toxicity. It has a well-documented profile of potential adverse effects related to its pharmacological action. Among those, myocardial damage, convulsions, and dysrhythmias are effects that may be encountered, especially in the context of improper administration or specific patient conditions.

Myocardial damage can occur due to the way calcium impacts cardiac function, particularly in patients with existing heart disease. Dysrhythmias may also arise from the alterations in calcium levels which are critical in cardiac electrical activity. Convulsions can happen if there is an underlying severe calcium imbalance; calcium plays a vital role in neuromuscular excitability and transmission.

On the other hand, pleural effusion is not a typical adverse effect associated with calcium gluconate. Pleural effusion refers to the accumulation of fluid in the pleural space and is more associated with conditions like heart failure, malignancies, or infections rather than direct pharmacological effects of calcium gluconate. Therefore, this option stands out as not being related to the usual adverse effects of administering calcium gluconate.